In the mechanism, MI-136, the inhibitor of menin–MLL, directly downregulated the expression of multiple components of the HIF pathway, such as Nos2/Nos3/Cav1, thereby inhibiting tumor growth [24] (Figure 2E). This evidence concerns the gene KMT2A and neoplasm.